These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32020403)

  • 1. Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
    Chen J; Zhu J; Zhang C; Song Y; Huang P
    Eur Radiol; 2020 May; 30(5):2871-2880. PubMed ID: 32020403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of contrast-enhanced ultrasound for differentiation of benign vs. malignant portal vein thrombosis in hepatocellular carcinoma - A systematic review a meta-analysis.
    Giri S; Vaidya A; Agrawal D; Varghese J; Patel RK; Tripathy T; Singh A; Das S
    Australas J Ultrasound Med; 2024 Feb; 27(1):56-64. PubMed ID: 38434544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography.
    Chammas MC; Oliveira AC; D Ávilla MJ; Moraes PH; Takahashi MS
    Ultrasound Med Biol; 2019 Jan; 45(1):50-55. PubMed ID: 30366607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
    Danila M; Sporea I; Popescu A; Șirli R
    Med Ultrason; 2016 Jun; 18(2):218-33. PubMed ID: 27239658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Kwon JH; Yoo SH; Nam SW; Lee YJ; Shin YR
    Anticancer Res; 2020 Aug; 40(8):4351-4363. PubMed ID: 32727763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound.
    Raza SA; Jang HJ; Kim TK
    Abdom Imaging; 2014 Feb; 39(1):153-61. PubMed ID: 24002440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
    Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
    Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma.
    Rossi S; Ghittoni G; Ravetta V; Torello Viera F; Rosa L; Serassi M; Scabini M; Vercelli A; Tinelli C; Dal Bello B; Burns PN; Calliada F
    Eur Radiol; 2008 Aug; 18(8):1749-56. PubMed ID: 18369630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of contrast enhanced ultrasound in the evaluation of the nature of portal vein thrombosis.
    Dănilă M; Sporea I; Popescu A; Sirli R; Sendroiu M
    Med Ultrason; 2011 Jun; 13(2):102-7. PubMed ID: 21655535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma.
    Burciu C; Șirli R; Bende F; Fofiu R; Popescu A; Sporea I; Ghiuchici AM; Miuțescu B; Dănilă M
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma.
    Cerrito L; Ainora ME; Di Francesco S; Galasso L; Gasbarrini A; Zocco MA
    Tomography; 2023 Oct; 9(5):1976-1986. PubMed ID: 37888746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
    Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
    Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
    Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
    Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
    Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
    J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.